CYP3A Mediates an Unusual C(sp 2 )−C(sp 3 ) Bond Cleavage via Ipso ‐Addition of Oxygen in Drug Metabolism
Angewandte Chemie International Edition · 03.06.2024 · 63 (23)
DOI: 10.1002/anie.202405197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 29.04.2024. Verfasst von Xuan Qin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Discovery, Department of Pathology and Immunology, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas, 77030, USA. Hauptthemen laut MEDLINE: Oxygen, Cytochrome P-450 CYP3A. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIA NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Mammalian cytochrome P450 drug‐metabolizing enzymes rarely cleave carbon–carbon (C−C) bonds and the mechanisms of such cleavages are largely unknown. We identified two unusual cleavages of non‐polar, unstrained C(sp 2 )−C(sp 3 ) bonds in the FDA‐approved tyrosine kinase inhibitor pexidartinib that are mediated by CYP3A4/5, the major human phase I drug metabolizing enzymes. Using a synthetic ketone, we rule out the Baeyer–Villiger oxidation mechanism that is commonly invoked to address P450‐mediated C−C bond cleavages. Our studies in 18 O 2 and H 2 18 O enriched systems reveal two unusual distinct mechanisms of C−C bond cleavage: one bond is cleaved by CYP3A‐mediated ipso ‐addition of oxygen to a C(sp 2 ) site of N ‐protected pyridin‐2‐amines, and the other occurs by a pseudo‐retro‐aldol reaction after hydroxylation of a C(sp 3 ) site. This is the first report of CYP3A‐mediated C−C bond cleavage in drug metabolism via ipso ‐addition of oxygen mediated mechanism. CYP3A‐mediated ipso ‐addition is also implicated in the regioselective C−C cleavages of several pexidartinib analogs. The regiospecificity of CYP3A‐catalyzed oxygen ipso ‐addition under environmentally friendly conditions may be attractive and inspire biomimetic or P450‐engineering methods to address the challenging task of C−C bond cleavages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Drug Discovery, Department of Pathology and Immunology, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas, 77030, USA.
- Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas, 77030, USA.
- National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Rd, Jefferson, Arkansas, USA.
- NMR and Drug Metabolism Core, Advanced Technology Cores, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas, 77030, USA.
ORCID-Profile: Feng Li
Förderung
- NICHD NIH HHS
- NIA NIH HHS
- NIDDK NIH HHS
- National Institute of Child Health and Human Development
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Aging
Zitieren
APA
Qin, X., Wang, Y., Ye, Q., Hakenjos, J. M., Wang, J., Teng, M., Guo, L., Tan, Z., Young, D. W., MacKenzie, K. R., & Li, F. (2024). CYP3A Mediates an Unusual C(sp 2 )−C(sp 3 ) Bond Cleavage via Ipso ‐Addition of Oxygen in Drug Metabolism. Angewandte Chemie International Edition, 63(23). https://doi.org/10.1002/anie.202405197
Vancouver
Qin X, Wang Y, Ye Q, Hakenjos JM, Wang J, Teng M, et al. CYP3A Mediates an Unusual C(sp 2 )−C(sp 3 ) Bond Cleavage via Ipso ‐Addition of Oxygen in Drug Metabolism. Angewandte Chemie International Edition. 2024;63(23). doi:10.1002/anie.202405197
BibTeX
@article{Qin2024,
author = {Qin, Xuan and Wang, Yong and Ye, Qiuji and Hakenjos, John M and Wang, Jin and Teng, Mingxing and Guo, Lei and Tan, Zhi and Young, Damian W and MacKenzie, Kevin R and Li, Feng},
title = {CYP3A Mediates an Unusual C(sp 2 )−C(sp 3 ) Bond Cleavage via Ipso ‐Addition of Oxygen in Drug Metabolism},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {23},
doi = {10.1002/anie.202405197}
}
EUVIMED